دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Reducing the risks of nuclear war: the role of health professionalsâ€
Kamran Abbasi1, Parveen Ali2, Virginia Barbour3, Kirsten Bibbins-Domingo4, Marcel G. M. Olde Rikkert5, Peng Gong6, Andy Haines7, Ira Helfand8, Richard Horton9, Bob Mash10, Arun Mitra8, Carlos Monteiro11, Elena N. Naumova12, Eric J. Rubin13, Tilman Ruff8, Peush Sahni14, James Tumwine15, Paul Yonga16 and Chris Zielinski
doi : 10.1093/brain/awad269
Distal hereditary motor neuropathy caused by coenzyme Q deficiency due to COQ7 variants
Maria Andrea Desbats1,2 and Leonardo Salviati
doi : 10.1093/brain/awad302
Can immunological imprinting drive neurological dysfunction in long COVID?
Dennis L. Kolson
doi : 10.1093/brain/awad307
Post-herpes simplex virus encephalitis autoimmunity: more the rule than the exception
Frank Leypoldt 1,2 and Klaus-Peter Wandinger
doi : 10.1093/brain/awad290
One transgene, two myopathies: an MTM1 ‘cross gene therapy’ for BIN1 deficiency?
Zeinab Asgarian,†Ala’a Siam†and John R. Counsell
doi : 10.1093/brain/awad310
The amyloid cascade hypothesis: an updated critical review
Kasper P. Kepp,1 Nikolaos K. Robakis,2 Poul F. H?ilund-Carlsen,3,4 Stefano L. Sensi 5,6 and Bryce Vissel 7
doi : 10.1093/brain/awad159
Clinical considerations in early-onset cerebral amyloid angiopathy
Gargi Banerjee,1 John Collinge,1 Nick C. Fox,2,3 Tammaryn Lashley,4,5 Simon Mead,1 Jonathan M. Schott,2,3 David J. Werring6 and Natalie S. Ryan
doi : 10.1093/brain/awad193
The coming of age of liquid biopsy in neuro-oncology
Giulia Berzero,1,2,†Valentina Pieri,1,†Pietro Mortini,2,3 Massimo Filippi1,2,4 and Gaetano Finocchiaro
doi : 10.1093/brain/awad195
Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1
Menelaos Pipis,1 Seongsik Won,2 Roy Poh,1 Stephanie Efthymiou,1 James M. Polke,1 Mariola Skorupinska,1 Julian Blake,1,3 Alexander M. Rossor,1 John J. Moran,2 Pinki Munot,4 Francesco Muntoni,4 Matilde Laura,1 John Svaren2,†and Mary M. Reilly
doi : 10.1093/brain/awad203
Gate control of sensory neurotransmission in peripheral ganglia by proprioceptive sensory neurons
Alice M. Fuller,1,2 Ana Luiz, 2 Naxi Tian,2 Manuel Arcangeletti, 2 Federico Iseppon, 2 Jane E. Sexton,2 Queensta Millet, 2 Sara Caxaria,1 Niloofar Ketabi,1 Petek Celik, 1 John N. Wood 2 and Shafaq Sikandar
doi : 10.1093/brain/awad182
Tau protein spreads through functionally connected neurons in Alzheimer’s disease: a combined MEG/PET study
Deborah N. Schoonhoven,1,2,3 Emma M. Coomans,2,3,4,5 Ana P. Mill?n,1,5 Anne M. van Nifterick,1,2,3 Denise Visser,2,3,4,5 Rik Ossenkoppele,2,3,4,5,6 Hayel Tuncel,3,4,5 Wiesje M. van der Flier,2,3 Sandeep S. V. Golla,3,4,5 Philip Scheltens,2,3 Arjan Hillebrand,1,5,7 Bart N. M. van Berckel,3,4,5 Cornelis J. Stam1,3 and Alida A. Gouw1
doi : 10.1093/brain/awad189
C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes
Cristina T. Vicente,1,2,†Jolien Perneel,1,2,†Sarah Wynants, 1,2 Bavo Heeman,1,2 Marleen Van den Broeck, 1,2 Matt Baker, 3 Simon Cheung,4 J?lia Faura, 1,2 Ian R. A. Mackenzie4,5 and Rosa Rademakers
doi : 10.1093/brain/awad133
Comprehension of acoustically degraded speech in Alzheimer’s disease and primary progressive aphasia
Jessica Jiang,1 Jeremy C. S. Johnson, 1 Maï-Carmen Requena-Komuro, 1,2 Elia Benhamou, 1 Harri Sivasathiaseelan, 1 Anthipa Chokesuwattanaskul, 1,3 Annabel Nelson, 1 Ross Nortley,1,4 Rimona S. Weil, 1 Anna Volkmer,5 Charles R. Marshall,6 Doris-Eva Bamiou,7 Jason D. Warren 1,†and Chris J. D. Hardy
doi : 10.1093/brain/awad163
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
Jon-Anders Tunold,1,2 Manuela M. X. Tan,1 Shunsuke Koga,3 Hanneke Geut,4 Annemieke J. M. Rozemuller,4,5,6 Rebecca Valentino,3 Hiroaki Sekiya,3 Nicholas B. Martin,3 Michael G. Heckman,7 Jose Bras,8,9 Rita Guerreiro,8,9 Dennis W. Dickson,3 Mathias Toft,1,2 Wilma D. J. van de Berg,4,6 Owen A. Ross3 and Lasse Pihlstr?m
doi : 10.1093/brain/awad183
Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS
Helena Motaln, 1 Ur?a C? erc?ek, 1,2 Alfred Yamoah, 3 Priyanka Tripathi, 3 Eleonora Aronica,4 Anand Goswami3,5,6,†and Boris Rogelj
doi : 10.1093/brain/awad130
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis
Alessio Maranzano,1 Federico Verde,1,2 Eleonora Colombo, 1 Barbara Poletti, 1 Alberto Doretti, 1 Ruggero Bonetti, 3 Delia Gagliardi, 2,4 Megi Meneri, 2,4 Luca Maderna, 1 Stefano Messina, 1 Stefania Corti,2,4 Claudia Morelli, 1 Vincenzo Silani1,2 and Nicola Ticozzi
doi : 10.1093/brain/awad129
SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency
Carolina Montoro-G?mez,1,2 Hendrik Nolte, 3 Thibaut Molinié, 1,2 Giovanna Evangelista, 1,2 Simon E. Tr?der, 2,4 Esther Barth,1,2 Milica Popovic,1,5 Aleksandra Trifunovic, 1,5,6 Branko Zevnik,2,4 Thomas Langer2,3 and Elena I. Rugarli1,
doi : 10.1093/brain/awad136
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3
Mafalda Raposo,1,2 Jeannette Hübener-Schmid,3,4 Ana F. Ferreira,2 Ana Rosa Vieira Melo, 2 Jo?o Vasconcelos, 5 Paula Pires, 6 Teresa Kay, 7 Hector Garcia-Moreno,8,9 Paola Giunti, 8,9 Magda M. Santana,10 Luis Pereira de Almeida, 10 Jon Infante,11 Bart P. van de Warrenburg, 12 Jeroen J. de Vries, 13 Jennifer Faber, 14,15 Thomas Klockgether, 14,15 Nicolas Casadei,3,16 Jakob Admard,3,16 Ludger Sch?ls,17,18 European Spinocerebellar ataxia type 3/Machado-Joseph disease Initiative (ESMI) study group, Olaf Riess3,4,16 and Manuela Lima
doi : 10.1093/brain/awad128
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response
Carlo Wilke,1,2 David Pellerin, 3 David Mengel,1,2 Andreas Traschütz, 1,2 Matt C. Danzi,4 Marie-Josée Dicaire, 3 Manuela Neumann,2,5 Holger Lerche, 6 Benjamin Bender,7 Henry Houlden, 8 RFC1 study group, Stephan Züchner,4 Ludger Sch?ls,2,9 Bernard Brais 3 and Matthis Synofzik
doi : 10.1093/brain/awad157
MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
Quentin Giraud, Coralie Spiegelhalter, Nadia Messaddeq and Jocelyn Laporte
doi : 10.1093/brain/awad251
Deep brain stimulation alleviates tics in Tourette syndrome via striatal dopamine transmission
Aaron E. Rusheen,1,2 Juan Rojas-Cabrera,1,2 Abhinav Goyal, 1,2 Hojin Shin,2,3 Jason Yuen,2,4 Dong-Pyo Jang,5 Keven E. Bennet,2,6 Charles D. Blaha, 2 Kendall H. Lee 2,3 and Yoonbae Oh
doi : 10.1093/brain/awad142
Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs
Adriana P. Rebelo,1 Pedro J. Tomaselli, 2 Jessica Medina, 1 Ying Wang,3 Maike F. Dohrn,1,4 Eva Nyvltova, 5 Matt C. Danzi,1 Mark Garrett,6 Sean E. Smith, 6 Alan Pestronk, 6 Chengcheng Li, 6 Ariel Ruiz,1 Elizabeth Jacobs,1 Shawna M. E. Feely, 7 Marcondes C. França Jr,2 Marcus V. Gomes,2 Diogo F. Santos,8 Surinder Kumar,9 David B. Lombard, 9 Mario Saporta, 1 Siegfried Hekimi,3 Antoni Barrientos,5 Conrad Weihl,6 Michael E. Shy, 7 Wilson Marques2 and Stephan Zuchner
doi : 10.1093/brain/awad158
Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects
Andreas Roos,1,2,3,†Peter F. M. van der Ven,4,†Hadil Alrohaif, 5,6 Heike K?lbel,1 Lorena Heil, 4 Adela Della Marina,1 Joachim Weis, 7 Marvin A?ent,4 Stefanie Beck-W?dl,8 Rita Barresi,9 Ana T?pf,5 Kaela O’Connor, 2 Albert Sickmann, 10 Nicolai Kohlschmidt, 11 Magdeldin El Gizouli, 12 Nancy Meyer,1 Nassam Daya,3 Valentina Grande, 4 Karin Bois,4 Frank J. Kaiser, 12 Matthias Vorgerd, 3 Christopher Schr?der, 12 Ulrike Schara-Schmidt, 1 Andrea Gangfuss,1 Teresinha Evangelista,5,13 Luisa R?bisch,10 Andreas Hentschel, 10 Anika Grüneboom, 10 Dieter O. Fuerst,4 Alma Kuechler,12 Andreas Tzschach, 14,†Christel Depienne
doi : 10.1093/brain/awad152
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1
Curtis A. Nutter,1,†Benjamin M. Kidd,1,†Helmut A. Carter, 1,†Johanna I. Hamel, 2 Philip M. Mackie, 3 Nayha Kumbkarni, 1 Mackenzie L. Davenport, 1 Dana M. Tuyn,1 Adithya Gopinath, 3 Peter D. Creigh, 2 ?ukasz J. Sznajder,1 Eric T. Wang, 1 Laura P. W. Ranum,4 Habibeh Khoshbouei, 3 John W. Day,5 Jacinda B. Sampson,5 Stefan Prokop6 and Maurice S. Swanson
doi : 10.1093/brain/awad148
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD)
Nicholas M. Allen,1,†Mark O’Rahelly,1 Bruno Eymard,2 Mondher Chouchane, 3 Andreas Hahn,4 Gerry Kearns,5 Dae-Seong Kim, 6 Shin Yun Byun, 7 Cam-Tu Emilie Nguyen,8 Ulrike Schara-Schmidt,9 Heike K?lbel, 9 Adela Della Marina, 9 Christiane Schneider-Gold,10 Kathryn Roefke, 11 Andrea Thieme,12 Peter Van den Bergh,13 Gloria Avalos, 14 Rodrigo ?lvarez-Velasco, 15 Daniel Natera-de Benito,16 Man Hin Mark Cheng,17 Wing Ki Chan, 17 Hoi Shan Wan,17 Mary Ann Thomas,18 Lauren Borch,18 Julie Lauzon,18 Cornelia Kornblum,19,20 Jens Reimann, 19 Andreas Mueller, 21 Thierry Kuntzer, 22 Fiona Norwood, 23 Sithara Ramdas, 24 Leslie W. Jacobson, 25 Xiaobo Jie, 25 Miguel A. Fernandez-Garcia, 26 Elizabeth Wraige,26 Ming Lim,26,27 Jean Pierre Lin,26 Kristl G. Claeys, 28,29 Selma Aktas,30 Maryam Oskoui, 31,32,33 Yael Hacohen,34,35 Ameneh Masud,36,37 M. Isabel Leite,25 Jacqueline Palace,25 Darryl De Vivo,36,37 Angela Vincent 25,†and Heinz Jungbluth
doi : 10.1093/brain/awad153
Bumetanide induces post-traumatic microglia–interneuron contact to promote neurogenesis and recovery
Marine Tessier,1 Marta Saez Garcia,2 Emmanuelle Goubert, 1 Edith Blasco, 1 Amandine Consumi, 1 Benoit Dehapiot,3 Li Tian,4 Florence Molinari, 5 Jerome Laurin, 1 François Guillemot, 6 Christian A. Hübner, 7 Christophe Pellegrino 1 and Claudio Rivera
doi : 10.1093/brain/awad132
The effects of cytomegalovirus on brain structure following sport-related concussion
Jonathan Savitz,1,2 Bryna D. Goeckner, 3 Bart N. Ford,4 T. Kent Teague,5,6,7 Haixia Zheng, 1 Jaroslaw Harezlak, 8 Rebekah Mannix, 9,10 L. Tugan Muftuler,11 Benjamin L. Brett,11,12 Michael A. McCrea 11,12 and Timothy B. Meier
doi : 10.1093/brain/awad126
Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization
Sun Ryu, Xuemei Liu, Tingting Guo, Zhaohua Guo, Jintao Zhang†and Yu-Qing Cao
doi : 10.1093/brain/awad191
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses
Marianna Spatola,1,†Nadège Nziza, 1,†Wonyeong Jung, 1,2 Yixiang Deng, 1,2 Dansu Yuan, 1 Alessandro Dinoto, 3 Silvia Bozzetti, 3 Vanessa Chiodega,3,4 Sergio Ferrari,3 Douglas A. Lauffenburger, 2 Sara Mariotto 3 and Galit Alter
doi : 10.1093/brain/awad155
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies
Tha?s Armangué,1,2 Gemma Olivé-Cirera,1,3 Eugenia Mart?nez-Hernandez,1,4 Maria Rodes,1 Vicente Peris-Sempere,5 Mar Guasp,1,4 Raquel Ruiz,6 Eduard Palou,6 Azucena Gonz?lez,6 Ma ?ngeles Marcos,7,8,9 Mar?a Elena Erro,10 Luis Bataller,11 ??igo Corral-Corral,12 Jesus Planagumà ,1 Eva Caballero,1 Alexandru Vlagea,6 Jie Chen,13 Paul Bastard,13,14,15,16 Marie Materna,14,15 Astrid Marchal,14,15 Laurent Abel,13,14,15 Aurélie Cobat,13,14,15 Laia Alsina,17,18,19 Clà udia Fortuny,18,20 Albert Saiz,1,4 Emmanuel Mignot,5 Adeline Vanderver,21,22 Jean-Laurent Casanova,13,14,15,23 Shen-Ying Zhang13,14,15,23 and Josep Dalmau1,22,24, on behalf of the Spanish HSE study group
doi : 10.1093/brain/awad238
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures
Carolina Campos-Rodriguez, 1,†Devin Palmer1,2,†and Patrick A. Forcelli
doi : 10.1093/brain/awad166
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants
Christopher J. Record,1 Mariola Skorupinska,1 Matilde Laura,1 Alexander M. Rossor,1 Davide Pareyson,2 Chiara Pisciotta,2 Shawna M. E. Feely,3 Thomas E. Lloyd,4 Rita Horvath,5 Reza Sadjadi,6 David N. Herrmann,7 Jun Li,8 David Walk,9 Sabrina W. Yum,10,11 Richard A. Lewis,12 John Day,13 Joshua Burns,14 Richard S. Finkel,15 Mario A. Saporta,16 Sindhu Ramchandren,17,18 Michael D. Weiss,19 Gyula Acsadi,20 Vera Fridman,21 Francesco Muntoni,22 Roy Poh,23 James M. Polke,23 Stephan Zuchner,24 Michael E. Shy,3 Steven S. Scherer10 and Mary M. Reilly1, for the Inherited Neuropathies Consortium—Rare Disease Clinical Research Network
doi : 10.1093/brain/awad187
Cdc42GAP deficiency contributes to the Alzheimer’s disease phenotype
Mengjuan Zhu,1,†Bin Xiao,1,†Tao Xue,1 Sifei Qin,1 Jiuyang Ding,2 Yue Wu,1 Qingqiu Tang,1 Mengfan Huang,1 Na Zhao,2 Yingshan Ye,1 Yuning Zhang,1 Boya Zhang,1 Juan Li,3 Fukun Guo,4 Yong Jiang,1 Lin Zhang3 and Lu Zhang
doi : 10.1093/brain/awad184
Intracranial stimulation and EEG feature analysis reveal affective salience network specialization
Brian A. Metzger,1 Prathik Kalva,2 Madaline M. Mocchi,2 Brian Cui,2 Joshua A. Adkinson,2 Zhengjia Wang,3 Raissa Mathura,2 Kourtney Kanja,2 Jay Gavvala,4 Vaishnav Krishnan,4 Lu Lin,4 Atul Maheshwari,4 Ben Shofty,5 John F. Magnotti,3 Jon T. Willie,6 Sameer A. Sheth2 and Kelly R. Bijanki
doi : 10.1093/brain/awad200
Glucocorticoid-driven mitochondrial damage stimulates Tau pathology
Fang Du, 1,†Qing Yu, 1,†Russell H. Swerdlow2 and Clarissa L. Waites
doi : 10.1093/brain/awad127
Randomizing for Alzheimer’s disease drug trials should consider the cancer history of participants
Viswanath Das and Mari?n Hajd?ch
doi : 10.1093/brain/awad177
A new diagnostic entity must enable earlier treatment in gene carriers
Jean Swidler, 1 Tucker Olson, 1 Amy L. Edelstein, 1 Julie Granning, 1 Cassandra Haddad,1 Mindy Uhrlaub 1 and Paul Wicks 1,2 , on behalf of the Genetic ALS & FTD: End The Legacy Group
doi : 10.1093/brain/awad164
Reply: A new diagnostic entity must enable earlier treatment in gene carriers
Michael Benatar,1 Ammar Al-Chalabi, 2 Anita Crawley 3 and Joanne Wuu
doi : 10.1093/brain/awad165
The correlation of behavioural deficits post-stroke: a trivial issue?
Lorenzo Pini,1,2 Antonio Luigi Bisogno,3 Alessandro Salvalaggio,1,3 Gordon L. Shulman4,5 and Maurizio Corbetta 1
doi : 10.1093/brain/awad173
Reply: The correlation of behavioural deficits post-stroke: a trivial issue?
Christoph Sperber, Laura Gallucci and Roza Umarova
doi : 10.1093/brain/awad174
Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
doi : 10.1093/brain/awad208
Correction: The most valuable player or the tombstone: is tau the correct target to treat Alzheimer’s disease?
doi : 10.1093/brain/awad176
Correction to: A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
doi : 10.1093/brain/awad207
Correction to: Establishing gene regulatory networks from Parkinson's disease risk loci
doi : 10.1093/brain/awad198
